Elevations of local leukotriene C4 levels during viral upper respiratory tract infections

Annals of Allergy, Asthma and Immunology

Volumn 91, Issue 3, 2003, Pages 270-274

  Gentile, Deborah A ^a   Fireman, Philip ^b   Skoner, David P ^a  

^a ALLEGHENY GENERAL HOSPITAL   (United States)

^b CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEUKOTRIENE C4;

ADULT; ANTIBODY BLOOD LEVEL; ARTICLE; CONTROLLED STUDY; HUMAN; INFLUENZA VIRUS A; MAJOR CLINICAL STUDY; MEDIATOR RELEASE; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RHINOVIRUS; UPPER RESPIRATORY TRACT INFECTION; VIRUS CULTURE; VIRUS INFECTION; VIRUS SHEDDING;

EID: 0141433324     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)63529-6     Document Type: Article

References (35)

1. Gwaltney JM. Upper respiratory infections, the common cold. In: Mandell GL, Bennet JE, Dolin R, editors. Principles and Practice of Infectious Diseases, 4th ed. New York, NY: Churchill Livingstone; 1995:561-566.
2. Turner RB. Epidemiology, pathogenesis, and treatment of the common cold. Ann Allergy Asthma Immunol. 1997;78:531-539.
3. Naclerio RM, Proud D, Lichtenstein LM, et al. Kinins are generated during experimental rhinovirus colds. J Infect Dis. 1988;157:133-142.
4. Doyle WJ, Skoner DP, White MV, et al. Patterns of nasal secretions during experimental influenza virus infection. Rhinology. 1996;34:2-8.
5. Skoner DP, Gentile DA, Fireman P, Cordoro K, Doyle WJ. Urinary histamine metabolite elevations during experimental influenza A infection. Ann Allergy Asthma Immunol. 2001;87:303-306.
6. Huftel MA, Swensen CA, Borcherding WR, et al. The effect of T-cell depletion on enhanced basophil histamine release after in vitro incubation with live influenza A virus. Am J Respir Cell Mol Biol. 1992;7:434-440.
7. Behera AK, Kumar M, Matsuse H, Lockey RF, Mohapatra SS. Respiratory syncytial virus induces the expression of 5-lipoxygenase and endothelin-1 in bronchial epithelial cells. Biochem Biophys Res Commun. 1998;251:704-709.
8. Kimpen JLL, Garofalo R, Welliver RC, Ogra PL. Activation of human eosinophils in vitro by respiratory syncytial virus. Pediatr Res. 1992;32:160-164.
9. Ananaba GA, Anderson LJ. Antibody enhancement of respiratory syncytial virus stimulation of leukotriene production by a macrophagelike cell line. J Virol. 1991;65:5052-5060.
10. Clementsen P, Bisgaard H, Pedersen M, et al. Staphylococcus aureus and influenza A virus stimulate human bronchoalveolar cells to release histamine and leukotrienes. Agents Actions. 1989;27:107-109.
11. 4 in respiratory tract during acute viral infection. J Pediatr. 1988;112:218-222.
12. van Schaik SM, Tristram DA, Nagpal IS, Hintz KM, Welliver RC 2nd, Welliver RC. Increased production of IFN-γ and cysteinyl leukotrienes in virus-induced wheezing. J Allergy Clin Immunol. 1999;103:630-636.
13. Volovitz B, Welliver RC, De Castro G, Krystofik DA, Ogra PL. The release of leukotrienes in the respiratory tract during infection with respiratory syncytial virus: role in obstructive airway disease. Pediatr Res. 1988;24:504-507.
14. 4 on mucosal blood flow, nasal airway resistance and nasal secretion in humans. Clin Allergy. 1986;16:289-297.
15. Gwaltney JM, Jordan W. Rhinovirus and respiratory illness in university students. Am Rev Respir Dis. 1966;93:362-371.
16. Tobita K, Sugiura A, Enomoto C, Furuyama M. Plaque assay and primary isolation of influenza A viruses in an established line of canine kidney cells (MDCK) in the presence of trypsin. Med Microbiol Immunol. 1975;162:9-14.
17. Anderson LJ, Hierholzer JC, Bingham PG, Stone YO. Microneutralization test for respiratory syncytial virus based on an enzyme immunoassay. J Clin Microbiol. 1985;22:1050-1052.
18. Michaels MG, Serdy C, Barbadora K, Green M, Apalsch A, Wald ER. Respiratory syncytial virus: a comparison of diagnostic modalities. Pediatr Infect Dis J. 1992;11:613-616.
19. Dowdle W, Kendal A, Noble G. Influenza viruses. In: Lenette E, Schmidt N, editors. Procedures for Viral, Rickettesial and Chlamydial Infections, 5th ed. Washington, DC: American Public Health Association; 1979:585-609.
20. Murphy BR, Phelan MA, Nelson DL, et al. Hemagglutinin-specific enzyme-linked immunosorbent assay for antibodies to influenza A and B viruses. J Clin Microbiol. 1981;13:554-560.
21. Meltzer EO, Malmstrom K, Lu S, et al. Concomitant montelukast and loratadine as treatment for seasonal allergic rhinitis: a randomized, placebo-controlled clinical trial. J Allergy Clin Immunol. 2000;105:917-922.
22. Liu YC, Khawaja AM, Rogers DF. Effects of the cysteinyl leukotriene receptor antagonists pranlukast and zafirlukast on tracheal mucus secretion in ovalbumin-sensitized guinea-pigs in vitro. Br J Pharmacol. 1998;124:563-571.
23. Naclerio RM, Baroody FM, Togias AG. The role of leukotrienes in allergic rhinitis: a review. Am Rev Respir Dis. 1991;143:S91-S95.
24. Skoner DP, Gentile DA, Patel A, Doyle WJ. Evidence for cytokine mediation of disease expression in adults experimentally infected with influenza A virus. J Infect Dis. 1999;180:10-14.
25. Cohen S, Doyle WJ, Skoner DP. Psychological stress, cytokine production, and severity of upper respiratory illness. Psychosom Med. 1999;61:175-180.
26. Gentile D, Doyle W, Whiteside T, Fireman P, Hayden FG, Skoner D. Increased interleukin-6 levels in nasal lavage samples following experimental influenza A virus infection. Clin Diagn Lab Immunol. 1998;5:604-608.
27. Proud D, Gwaltney JM Jr, Hendley JO, Dinarello CA, Gillis S, Schleimer RP. Increased levels of interleukin-1 are detected in nasal secretions of volunteers during experimental rhinovirus colds. J Infect Dis. 1994;169:1007-1013.
28. Hayden FG, Fritz R, Lobo MC, Alvord W, Strober W, Straus SE. Local and systemic cytokine responses during experimental influenza A virus infection. Relation to symptom formation and host defense. J Clin Invest. 1998;101:643-649.
29. Turner RB, Weingand KW, Chyon-Hwa Y, Leedy DW. Association between interleukin-8 concentration in nasal secretions and severity of symptoms of experimental rhinovirus colds. Clin Infect Dis. 1998;26:840-846.
30. 4 administration in the guinea pig. Am J Respir Crit Care Med. 1996;154:850-857.
31. Ihaku D, Cameron L, Suzuki M, Molet S, Martin J, Hamid Q. Montelukast, a leukotriene receptor antagonist, inhibits the late airway response to airway eosinophilia, and IL-5 expressing cells in Brown Norway rats. J Allergy Clin Immunol. 1999;104:1147-1154.
32. Yoon HJ, Zhu Z, Gwaltney JM, Elias JA. Rhinovirus regulation of IL-1 receptor antagonist in vivo and in vitro: a potential mechanism of symptom resolution. J Immunol. 1999;162:7461-7469.
33. Gentile DA, Patel A, Ollila C, et al. Diminished IL-10 production in subjects with allergy after infection with influenza A virus. J Allergy Clin Immunol. 1999;103:1045-1048.
34. Doyle WJ, Skoner DP, Alper CM, et al. Effect of rimantadine treatment on clinical manifestations and otological complications in adults experimentally infected with influenza A (H1N1) virus. J Infect Dis. 1998;177:1260-1265.
35. Hode DS. Respiratory infections and sinusitis. In: Katz SL, Gershon AA, Hotez RT, editors. Krugman's Infectious Diseases of Children, 10th ed. St. Louis, MO: Mosby-Yearbook; 1998:366-368.